Clinical Trial

Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 20, 2024 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this prospective observational study is to investigate the incidence of Medication Related Osteonecrosis of the Jaws (MRONJ) in patients receiving antiresorptive drugs for oncohematologic reasons during a 5-year follow-up. Secondary objectives are to compare the different antiresorptive drugs in relation to the incidence of MRONJ and to identify any systemic as well as local risk factors.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-08.
Trial Details
NCT Number NCT06457776
Lead Sponsor Catholic University of the Sacred Heart
Conditions Osteonecrosis of the Jaw, Osteonecrosis Due to Drugs, Jaw, Osteonecrosis Due to Drug, Bisphosphonate-Associated Osteonecrosis, Bisphosphonate-Associated Osteonecrosis of the Jaw
Enrollment 126 participants
Start Date 2021-01-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-06-20